These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 2507799

  • 1. [Susceptibility of clinical isolates to aztreonam].
    Nagasawa Z, Nishimura T, Nagumo F, Ueda H, Tadano J, Katoh O, Yamada H.
    Jpn J Antibiot; 1989 Jun; 42(6):1257-70. PubMed ID: 2507799
    [Abstract] [Full Text] [Related]

  • 2. [Susceptibility of clinical bacterial isolates to aztreonam].
    Murase M, Niiya T, Takeuchi N.
    Jpn J Antibiot; 1987 Sep; 40(9):1698-706. PubMed ID: 3121888
    [Abstract] [Full Text] [Related]

  • 3. [Post-marketing surveillance of antibacterial activities of cefozopran against various clinical isolates--II. Gram-negative bacteria].
    Igari J, Oguri T, Hiramatsu N, Akiyama K, Koyama T.
    Jpn J Antibiot; 2002 Feb; 55(1):22-60. PubMed ID: 11977920
    [Abstract] [Full Text] [Related]

  • 4. [Susceptibility of clinically isolated strains to aztreonam].
    Daimon Y.
    Jpn J Antibiot; 1988 Nov; 41(11):1623-34. PubMed ID: 3145344
    [Abstract] [Full Text] [Related]

  • 5. [Antibacterial activity of aztreonam against clinical isolates].
    Igari J.
    Jpn J Antibiot; 1994 May; 47(5):502-20. PubMed ID: 8051793
    [Abstract] [Full Text] [Related]

  • 6. [Antibacterial activities of monobactams against fresh clinical isolates].
    Deguchi K, Yokota N, Koguchi M, Nakane Y, Fukayama S, Nishimura Y, Oda S, Tanaka S, Kato M, Sato K.
    Jpn J Antibiot; 1988 Nov; 41(11):1600-22. PubMed ID: 3210297
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Susceptibilities of bacteria isolated from patients with respiratory infectious diseases to antibiotics (1992)].
    Ikemoto H, Watanabe K, Mori T, Igari J, Oguri T, Kobayashi K, Satou K, Matsumiya H, Saito A, Terai T, Tanno Y, Nishioka K, Arakawa M, Wada K, Okada M, Ozaki K, Aoki N, Kitamura N, Sekine O, Suzuki Y, Tanimoto H, Nakata K, Nakamori Y, Nakatani T, Kusano N.
    Jpn J Antibiot; 1996 Jan; 49(1):34-70. PubMed ID: 8851305
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Susceptibility of clinical isolates to aztreonam].
    Asari S, Horikawa M, Tsukamoto H, Kouda K, Hayashi C, Miyai K.
    Jpn J Antibiot; 1987 Jul; 40(7):1317-31. PubMed ID: 3479624
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Combined antibacterial activity of aztreonam and clindamycin against clinically isolated strains].
    Deguchi K, Yokota N, Koguchi M, Nakane Y, Suzuki Y, Fukayama S, Ishihara R, Oda S.
    Jpn J Antibiot; 1991 May; 44(5):529-37. PubMed ID: 1880932
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.